BioCentury

2:11 AM GMT, Nov 18, 2009
This article and the information contained in BioCentury's publications and services are solely for your own personal, non-transferable licensed use and cannot be shared with any other individuals. For information about adding subscribers to your account or obtaining article reprints, please contact support@biocentury.com.
Clinical News

Isis falls after mipomersen update

Isis Pharmaceuticals Inc. (NASDAQ:ISIS) fell $2.28 (17%) to $11.12 on Tuesday after it and partner

Read the full 153 word article

This article and the information contained in BioCentury's publications and services are solely for your own personal, non-transferable licensed use and cannot be shared with any other individuals. For information about adding subscribers to your account or obtaining article reprints, please contact support@biocentury.com.